Other OTC - Delayed Quote • USD
Calithera Biosciences, Inc. (CALA)
At close: April 26 at 9:30 AM EDT
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
9,750.0000
--
Operating Expense
42,074.0000
42,074.0000
74,308.0000
91,387.0000
Operating Income
-42,074.0000
-42,074.0000
-64,558.0000
-91,387.0000
Net Non Operating Interest Income Expense
477.0000
477.0000
345.0000
1,250.0000
Other Income Expense
1,947.0000
1,947.0000
-50,875.0000
--
Pretax Income
-39,650.0000
-39,650.0000
-115,088.0000
-90,137.0000
Net Income Common Stockholders
-21,290.0000
-21,290.0000
-115,088.0000
-90,137.0000
Average Dilution Earnings
-18,360.0000
-18,360.0000
--
--
Diluted NI Available to Com Stockholders
-39,650.0000
-39,650.0000
-115,088.0000
-90,137.0000
Basic EPS
-4.60
--
-31.16
-26.20
Diluted EPS
-7.94
--
-31.16
-26.20
Basic Average Shares
4,633.0000
--
3,693.0000
3,441.0000
Diluted Average Shares
4,992.0000
--
3,693.0000
3,441.0000
Total Operating Income as Reported
-42,074.0000
-42,074.0000
-115,433.0000
-91,387.0000
Total Expenses
42,074.0000
42,074.0000
74,308.0000
91,387.0000
Net Income from Continuing & Discontinued Operation
-39,650.0000
-39,650.0000
-115,088.0000
-90,137.0000
Normalized Income
-41,597.0000
-41,597.0000
-64,213.0000
-90,137.0000
Interest Income
477.0000
477.0000
345.0000
1,250.0000
Net Interest Income
477.0000
477.0000
345.0000
1,250.0000
EBIT
-42,074.0000
-42,074.0000
-64,558.0000
-91,387.0000
EBITDA
-41,819.0000
-41,819.0000
-64,278.0000
-91,023.0000
Reconciled Depreciation
255.0000
255.0000
280.0000
364.0000
Net Income from Continuing Operation Net Minority Interest
-39,650.0000
-39,650.0000
-115,088.0000
-90,137.0000
Total Unusual Items Excluding Goodwill
1,947.0000
1,947.0000
-50,875.0000
--
Total Unusual Items
1,947.0000
1,947.0000
-50,875.0000
--
Normalized EBITDA
-43,766.0000
-43,766.0000
-13,403.0000
-91,023.0000
12/31/2020 - 10/2/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
APLMW Apollomics, Inc.
0.0260
0.00%
SYBE Sybleu Inc.
0.0590
-25.38%
EVLO Evelo Biosciences, Inc.
0.0495
+8.32%
ENDV Endonovo Therapeutics, Inc.
0.0026
+9.58%
LIANY LianBio
0.2808
-5.77%
SBM.V Sirona Biochem Corp.
0.0650
-7.14%
SLGL Sol-Gel Technologies Ltd.
0.8896
-0.04%
AGNPF Algernon Pharmaceuticals Inc.
0.0914
+4.86%
IMAB I-Mab
1.8000
-0.55%
NTBL Notable Labs, Ltd.
0.9650
-0.27%